Glaucoma pressure fight: new device vs laser – which wins?

NCT ID NCT02928289

Terminated Disease control Sponsor: Sight Sciences, Inc. Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 19, 2026 · Updated 33 times

Summary

This study tested a new device called VISCO360 against a standard laser treatment (SLT) to lower eye pressure in adults with open-angle glaucoma. The goal was to see which procedure is safer and more effective. The study was stopped early and included 29 people who had already had cataract surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OPEN-ANGLE GLAUCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Coastal Vision Medical Group

Orange, California, 92868, United States
Dean McGee Eye Institute

Oklahoma City, Oklahoma, 73104, United States
El Paso Eye Surgeons

El Paso, Texas, 79902, United States
Ophthalmology Associates

Fort Worth, Texas, 76102, United States
Vold Vision

Fayetteville, Arkansas, 72704, United States
Wills Eye Hospital

Philadelphia, Pennsylvania, 19107, United States

Conditions

Explore the condition pages connected to this study.

OPEN-ANGLE GLAUCOMA